Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen H Weishaupt

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Cell Cycle (Georgetown, Tex.)|March 1, 2012
Sumoylation fights "aggregopathies"Petranka Krumova, Jochen H Weishaupt
Current Opinion in Neurology|July 24, 2019
Update on amyotrophic lateral sclerosis geneticsDavid Brenner, Jochen H Weishaupt
Cellular and Molecular Life Sciences : CMLS|September 26, 2012
Sumoylation in neurodegenerative diseasesPetranka Krumova, Jochen H Weishaupt
Trends in Molecular Medicine|August 8, 2016
Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal DementiaJochen H Weishaupt, Tony Hyman, Ivan Dikic
Journal of Molecular Neuroscience : MN|June 22, 2005
Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cellsJochen H Weishaupt, Nikolaj Klöcker, Mathias Bähr
Journal of Neurology|March 14, 2012
Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumabJochen H Weishaupt, Claudia Ganser, Mathias Bähr
Current Opinion in Neurology|August 25, 2012
Amyotrophic lateral sclerosisAlbert C Ludolph, Johannes Brettschneider, Jochen H Weishaupt
Medizinische Monatsschrift Fur Pharmazeuten|January 31, 2015
[Amyotrophic lateral sclerosis]Annemarie Hübers, Jochen H Weishaupt, Albert C Ludolph
Neurological Research and Practice|December 16, 2020
Gene specific therapies - the next therapeutic milestone in neurologyDavid Brenner, Albert C Ludolph, Jochen H Weishaupt
Neuro-Degenerative Diseases|August 16, 2006
Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical applicationPawel Kermer, Jan Liman, Jochen H Weishaupt, et al.
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Cell Cycle (Georgetown, Tex.)|March 1, 2012
Sumoylation fights "aggregopathies"Petranka Krumova, Jochen H Weishaupt
Current Opinion in Neurology|July 24, 2019
Update on amyotrophic lateral sclerosis geneticsDavid Brenner, Jochen H Weishaupt
Cellular and Molecular Life Sciences : CMLS|September 26, 2012
Sumoylation in neurodegenerative diseasesPetranka Krumova, Jochen H Weishaupt
Trends in Molecular Medicine|August 8, 2016
Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal DementiaJochen H Weishaupt, Tony Hyman, Ivan Dikic
Journal of Molecular Neuroscience : MN|June 22, 2005
Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cellsJochen H Weishaupt, Nikolaj Klöcker, Mathias Bähr
Journal of Neurology|March 14, 2012
Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumabJochen H Weishaupt, Claudia Ganser, Mathias Bähr
Current Opinion in Neurology|August 25, 2012
Amyotrophic lateral sclerosisAlbert C Ludolph, Johannes Brettschneider, Jochen H Weishaupt
Medizinische Monatsschrift Fur Pharmazeuten|January 31, 2015
[Amyotrophic lateral sclerosis]Annemarie Hübers, Jochen H Weishaupt, Albert C Ludolph
Neurological Research and Practice|December 16, 2020
Gene specific therapies - the next therapeutic milestone in neurologyDavid Brenner, Albert C Ludolph, Jochen H Weishaupt
Neuro-Degenerative Diseases|August 16, 2006
Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical applicationPawel Kermer, Jan Liman, Jochen H Weishaupt, et al.
Pageof 18